First, can you start by explaining why GLP-1 medications have become such a hot topic in employee health benefits?

Yeah, absolutely.

That's a, that's a great question.

I, I think it really comes down to sort of the convergence of several things that have happened recently.

One being that for the first time, we have a treatment that works for obesity, which is something that prior to this has not really been available, um, and it's worked better than anything else.

Um, secondly, we've had a lot of new indications, which are approvals for, uh, the treatment of other things outside of diabetes and obesity for these medications.

So the uses are just expanding, um, it feels like on a daily basis, even though I know that's not technically true.

Right.